Webinar on the Role of Omega-3 Fatty Acids in Cardiovascular Health – EAS
European Atherosclerosis Society shared a post on LinkedIn:
“The second webinar of the series will explore the latest research on the role of omega – 3 fatty acids in cardiovascular health.
Leading experts will share their insights on how icosapent ethyl and marine omega – 3 fatty acids influence lipoprotein remodeling and cardiovascular disease (CVD) risk markers, especially in normolipidemic individuals.
Maria Cherska, The Head of Cardiology Department at The State Institution «V.P. Komisarenko Institute of Endocrinology and Metabolism», reposted European Atherosclerosis Society’s post on LinkedIn, adding:
“In this session, leading experts will unpack how icosapent ethyl and marine – derived omega – 3s contribute to lipoprotein remodeling and modulate key cardiovascular risk markers – with particular focus on individuals with normolipidemia.
A valuable discussion for those interested in the evolving science behind residual risk and lipid biology.”
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 20, 2026, 05:33Giulia Di Paolo: Connecting Plasma Donation to the Patients Who Depend on It
-
Oct 20, 2026, 05:20James Knowles: Exploring Plasma Manufacturing and Strengthening Industry Collaboration
-
Oct 20, 2026, 05:11Giuseppe Lippi։ Understanding Liver Test Abnormalities After AAV Gene Therapy
-
Oct 20, 2026, 05:02Sanam Loghavi: Test Your Hematology Knowledge at ASH 2026!
-
Oct 20, 2026, 04:13Ifeanyichukwu Ifechidere: DOACs Are Not the Answer to Every Anticoagulation Question
-
Oct 20, 2026, 04:04Sadia Kamal: Honored to Receive the Outstanding Abstract Award at the 20th Midwest Platelet Conference
-
Oct 20, 2026, 04:03Yu-Hsuan Chen: One Antibody, Two Diseases from FcRn Biology to Clinical Translation
-
Oct 20, 2026, 03:49Domenico Simone Castiello: Rethinking Prolonged DAPT in Multivessel PCI – Insights from the DAPT-MVD Trial
-
Oct 20, 2026, 03:37Rucha Patil: Scaling POC Diagnostics for Haemophilia A and VWD Across India